Free Trial

RenovoRx (RNXT) SEC Filings & 10K Form

RenovoRx logo
$1.01 +0.02 (+2.01%)
As of 02:36 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent RenovoRx SEC Filings

DateFilerForm TypeView
04/17/2025
5:10 AM
Agah Ramtin (Reporting)
RenovoRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2025
4:18 PM
Agah Ramtin (Reporting)
RenovoRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2025
4:18 PM
Kocak Ron (Reporting)
RenovoRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2025
4:18 PM
Gentry Leesa (Reporting)
RenovoRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2025
4:18 PM
Bagai Shaun (Reporting)
RenovoRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2025
5:08 AM
Bagai Shaun (Reporting)
RenovoRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2025
5:30 AM
Agah Ramtin (Reporting)
RenovoRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2025
6:02 PM
Kocak Ron (Reporting)
RenovoRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2025
3:30 PM
Agah Ramtin (Reporting)
RenovoRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2025
5:02 AM
Bagai Shaun (Reporting)
RenovoRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
8:30 PM
Marton Laurence (Reporting)
RenovoRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
11:45 AM
Agah Ramtin (Reporting)
RenovoRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2025
10:30 AM
Bagai Shaun (Reporting)
RenovoRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
8:00 AM
RenovoRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2025
4:11 PM
RenovoRx (Filer)
Form NT 10-K
02/10/2025
8:12 AM
RenovoRx (Filer)
Form 424B5
02/10/2025
8:14 AM
RenovoRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
7:30 AM
RenovoRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
3:15 PM
RenovoRx (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/25/2024
3:10 PM
RenovoRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
3:41 PM
RenovoRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2024
11:15 PM
RenovoRx (Filer)
Form EFFECT
05/12/2024
11:15 PM
RenovoRx (Filer)
Form EFFECT
05/10/2024
4:21 PM
RenovoRx (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2024
3:47 PM
RenovoRx (Filer)
Form 424B3
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RNXT) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners